Columnists
Tipsheet
Cartoons
Podcasts
Newsletters
Sections
Podcasts
Townhall TV
Election
Capitol Voices
Entertainment
Radio News
Live Blog
Topics
Sites
Hot Air
PJ Media
Bearing Arms
Twitchy
RedState
JOIN VIP
LOGIN
MY ACCOUNT
Account Settings
Newsletter Subscriptions
Log Out
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Monopar Therapeutics Inc. - Common Stock
(NQ:
MNPR
)
25.82
+2.03 (+8.53%)
Streaming Delayed Price
Updated: 4:00 PM EST, Dec 20, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
139,076
Open
30.40
Bid (Size)
24.00 (3)
Ask (Size)
29.91 (1)
Prev. Close
23.79
Today's Range
23.66 - 30.40
52wk Range
1.545 - 38.50
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
12 Health Care Stocks Moving In Friday's Pre-Market Session
December 20, 2024
Via
Benzinga
Monopar Therapeutics Inc. Announces Pricing of $40 Million Public Offering of Common Stock and Concurrent Private Placement of Pre-Funded Warrants
December 20, 2024
From
Monopar Therapeutics Inc.
Via
GlobeNewswire
Performance
YTD
+1295.68%
+1295.68%
1 Month
+31.00%
+31.00%
3 Month
+490.85%
+490.85%
6 Month
+546.31%
+546.31%
1 Year
+1196.84%
+1196.84%
More News
Read More
Monopar Announces First Patient Dosed with its Novel Therapeutic Radiopharmaceutical MNPR-101-Lu
December 05, 2024
From
Monopar Therapeutics Inc.
Via
GlobeNewswire
Monopar to Present at the 36th Annual Piper Sandler Healthcare Conference
December 03, 2024
From
Monopar Therapeutics Inc.
Via
GlobeNewswire
3 Momentum Stocks Soaring Into 2025 and Beyond
December 03, 2024
Via
MarketBeat
Topics
Stocks
Exposures
US Equities
Monopar Therapeutics Reports Third Quarter 2024 Financial Results and Recent Developments
November 08, 2024
From
Monopar Therapeutics Inc.
Via
GlobeNewswire
Monopar Therapeutics Inc. Announces Pricing of $19.2 Million Public Offering of Common Stock
October 28, 2024
From
Monopar Therapeutics Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Monday's After-Market Session
October 28, 2024
Via
Benzinga
Monopar Therapeutics Inc. Announces Proposed Public Offering of Common Stock
October 28, 2024
From
Monopar Therapeutics Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Monday's Pre-Market Session
October 28, 2024
Via
Benzinga
Why LENZ Therapeutics Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket
October 28, 2024
Via
Benzinga
MarketBeat Week in Review – 10/21- 10/25
October 26, 2024
Via
MarketBeat
Topics
Artificial Intelligence
Economy
Stocks
Exposures
Artificial Intelligence
Economy
Interest Rates
12 Health Care Stocks Moving In Friday's Intraday Session
October 25, 2024
Via
Benzinga
What's Going On With Monopar Therapeutics Shares Friday?
October 25, 2024
Via
Benzinga
Monopar Therapeutics Skyrockets 400% on Licensing Deal
October 25, 2024
Via
MarketBeat
Exposures
COVID-19
12 Health Care Stocks Moving In Friday's Pre-Market Session
October 25, 2024
Via
Benzinga
Why Deckers Outdoor Shares Are Trading Higher By Around 14%; Here Are 20 Stocks Moving Premarket
October 25, 2024
Via
Benzinga
Monopar Therapeutics, Intellia Therapeutics, Capri Holdings, Western Digital, And Tesla: Why These 5 Stocks Are On Investors' Radars Today
October 24, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Monopar Therapeutics Stock Jumps 4X, Inks Licensing Pact With AstraZeneca For Once Terminated Phase 3 Candidate For Rare Genetic Disorder
October 24, 2024
Via
Benzinga
Monopar Announces Agreement with Alexion, AstraZeneca Rare Disease For Late-Stage Wilson Disease Drug Candidate
October 24, 2024
From
Monopar Therapeutics Inc.
Via
GlobeNewswire
Monopar Presents Encouraging Human Clinical Dosimetry Data on its uPAR Program at EANM 2024
October 22, 2024
From
Monopar Therapeutics Inc.
Via
GlobeNewswire
Monopar Expands Radiopharma Intellectual Property Portfolio with Patent Filing on New Compounds and Linkers
October 15, 2024
From
Monopar Therapeutics Inc.
Via
GlobeNewswire
Monopar Initiates Clinical Trial of Novel uPAR-Targeted Radiopharmaceutical Therapy in Advanced Cancers
October 07, 2024
From
Monopar Therapeutics Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Tuesday's Intraday Session
October 01, 2024
Via
Benzinga
Why Monopar Therapeutics (MNPR) Stock Is Skyrocketing Today
September 12, 2024
Via
Benzinga
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.